Evaluation Studies - DNA Vaccine Expressing Sivsm Vlp - Edmundo Kraiselburd

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research Project (R01)
Project #: 5R01AI044592-02
Application #: 6170901
Study Section: Special Emphasis Panel (ZRG5-AARR-2 (04))
Program Officer: Bradac, James A

Project Start: 1999-05-01
Project End: 2002-04-30
Budget Start: 2000-05-01
Budget End: 2001-04-30
Support Year: 2
Fiscal Year: 2000
Total Cost: $528,455
Indirect Cost

Institution

Name: University of Puerto Rico Med Sciences
Department: Microbiology/Immun/Virology
Type: Schools of Medicine
DUNS #

City: San Juan
State: PR
Country: United States
Zip Code: 00936

Related projects


NIH 2001 R01 AI	Evaluation Studies - DNA Vaccine Expressing Sivsm Vlp Kraiselburd, Edmundo Nelson / University of Puerto Rico Med Sciences	$433,477
NIH 2000 R01 AI	Evaluation Studies - DNA Vaccine Expressing Sivsm Vlp Kraiselburd, Edmundo Nelson / University of Puerto Rico Med Sciences	$528,455
NIH 2000 R01 AI	Evaluation Studies - DNA Vaccine Expressing Sivsm Vlp Kraiselburd, Edmundo Nelson / University of Puerto Rico Med Sciences	$48,421
NIH 1999 R01 AI	Evaluation Studies - DNA Vaccine Expressing Sivsm Vlp Kraiselburd, Edmundo Nelson / University of Puerto Rico Med Sciences

Publications

O'Neill, E; Martinez, I; Villinger, F et al. (2002) Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration. J Med Primatol 31:217-27

Comments

Be the first to comment on Edmundo Kraiselburd's grant